Clearside Biomedical, Inc.CLSDNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank8
Year-over-Year Change
Year-over-year total asset growth rate
Percentile
P8
Near historical low
vs 3Y Ago
-0.3x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -24.07% |
| Q2 2025 | -22.05% |
| Q1 2025 | -21.72% |
| Q4 2024 | -13.84% |
| Q3 2024 | -14.07% |
| Q2 2024 | -15.47% |
| Q1 2024 | 18.00% |
| Q4 2023 | -1.17% |
| Q3 2023 | -12.16% |
| Q2 2023 | -12.33% |
| Q1 2023 | -12.88% |
| Q4 2022 | -7.87% |
| Q3 2022 | 81.11% |
| Q2 2022 | -14.73% |
| Q1 2022 | -15.95% |
| Q4 2021 | 56.71% |
| Q3 2021 | -4.25% |
| Q2 2021 | 2.77% |
| Q1 2021 | 43.99% |
| Q4 2020 | 11.01% |
| Q3 2020 | -1.88% |
| Q2 2020 | -29.17% |
| Q1 2020 | -6.47% |
| Q4 2019 | 3.51% |
| Q3 2019 | -13.35% |
| Q2 2019 | -20.46% |
| Q1 2019 | -14.93% |
| Q4 2018 | -36.41% |
| Q3 2018 | -21.17% |
| Q2 2018 | -15.74% |
| Q1 2018 | 157.98% |
| Q4 2017 | -26.21% |
| Q3 2017 | -19.79% |
| Q2 2017 | -16.52% |
| Q1 2017 | -3.37% |
| Q4 2016 | 46.81% |
| Q3 2016 | 2.86% |
| Q2 2016 | 232.08% |
| Q1 2016 | -19.67% |
| Q4 2015 | 366.23% |